Depakote Birth Defect Lawsuit Over Spina Bifida Filed

An Illinois mother has filed a lawsuit against Abbott Laboratories, alleging that her daughter suffered a birth defect known as spina bifida from Depakote use during pregnancy. 

The complaint was filed by Rhealyn Alexander in St. Clair County Circuit Court on October 17, arguing that the drug maker failed to adequately warn that use during pregnancy could cause birth defects due to side effects of Depakote.

Alexander’s daughter was born with spina bifida in October 2007, which is a neural tube defect that occurs when some vertebrae overlying the spinal cord are not fully formed and remain fused and open.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The Depakote birth defect lawsuit accuses Abbott of negligence, and seeks compensatory damages for medical expenses, loss of income and legal fees.

Depakote was approved in the United States in 1978 for treatment of certain forms of epilepsy. However, Depakote pregnancy use has been linked to an increased risk of a number of severe birth defects, especially when the drug is taken during the first 28 days, when neural tube closure and other critical formations are taking place.

In 2006, the FDA added a “black box” warning about the potential risk of Depakote birth defects after a study found that 20% of pregnant mothers who gave birth while on Depakote had a child with malformations or a birth defect. In addition to spina bifidia, other birth defects associated with Depakote include, cleft palate, abnormal skull development, malformed limbs, holes in the heart and urinary tract problems.

In May 2010, researchers found that Depakote problems for infants could occur after using the drug as early as the first trimester, which means that by the time many women discover they are pregnant, it could be too late to get off the drug and avoid birth defects for their unborn child. The FDA also recently issued warnings that Depakote and similar drugs may be linked to cognitive impairments in newborns as well.

In recent months, a number of similar Depakote lawsuits over spina bifida and other birth defects suffered by children born to women who were given the epilepsy drug during pregnancy. The complaints allege that Abbott failed to adequately research the medication or warn consumers about the risks associated with becoming pregnant, placing their desire for profits before patients safety.

Earlier this week, it was reported that Abbott recently agreed to pay $1.3 billion to settle claims by the federal government that the company illegally marketed Depakote by promoting it for uses not approved by the FDA. The company is expected to pay about $800 million to address claims of off-label marketing, and $500 million in criminal fines. While neither Abbott or the Department of Justice (DOJ) has confirmed the amounts involved, both have said that a settlement in the works.

While doctors are able to prescribe a drug for whatever need they see fit, it is illegal for companies to promote a drug for uses that have not been approved by the FDA.


Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted yesterday)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted 2 days ago)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.